XML 33 R17.htm IDEA: XBRL DOCUMENT v3.19.1
Note 11 - Stock Compensation
12 Months Ended
Dec. 31, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
11.
STOCK COMPENSATION
 
 
The Company's
2013
Omnibus Equity Plan was approved and adopted by an affirmative vote of a majority of the Company's Class A and Class B Shareholders and provides for the grant of the following types of incentive awards: stock options, stock appreciation rights, restricted shares, restricted share units, performance shares and Class A Common Shares. Those who will be eligible for awards under the
2013
Omnibus Plan include employees who provide services to the Company and its affiliates, executive officers, non-employee Directors and consultants designated by the Compensation Committee. The Plan has
150,000
Class A Common Shares reserved for issuance. The Class A Common Shares
may
be either authorized, but unissued, common shares or treasury shares. There were
no
share-based awards granted during the
three
months ended
December 31, 2018
or
2017.
The Company granted
30,333
and
36,333
restricted stock awards under the
2013
Omnibus Equity Plan during the fiscal years ended
December 31, 2018
and
September 30, 2017,
respectively.

The Company's expired Outside Directors Stock Option Plans (collectively the "Directors Plans"), provided for the automatic grant of options to purchase up to
5,000
shares of Class A Common Stock over a
three
-year period to members of the Board of Directors who were
not
employees of the Company, at the fair market value on the date of grant. The options are exercisable for up to
10
years. All options granted under the Directors Plans became fully exercisable on
March 8, 2015.
 
Non-cash compensation expense related to stock option plans was
$394,933
and
$129,832
for the fiscal years ended
December 31, 2018
and
September 30, 2017,
respectively. The Company did
not
incur any non-cash compensation expense for the
three
months ended
December 31, 2017
and
2016,
respectively.